Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions

por Garin, Noe, Sole, Nuria, Lucas, Beatriz, Matas, Laia, Moras, Desiree, Rodrigo-Troyano, Ana, Gras-Martin, Laura, Fonts, Nuria
Publicado 2021

Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2

por Corominas, Hèctor, Castellví, Ivan, Diaz-Torné, César, Matas, Laia, de la Rosa, David, Mangues, Maria Antònia, Moya, Patricia, Pomar, Virginia, Benito, Natividad, Moga, Ester, Sosa, Nerea Hernandez-de, Casademont, Jordi, Domingo, Pere
Publicado 2021

Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort()

por Corominas, Hèctor, Castellví, Ivan, Pomar, Virginia, Antonijoan, Rosa, Mur, Isabel, Matas, Laia, Gich, Ignasi, de Benito, Natividad, Laiz, Ana, Castillo, Diego, Villamarin, Laura, Filella, David, Millán, Ana Milena, Quijada, María Ángeles, Puig, Mireia, Casademont, Jordi, Domingo, Pere
Publicado 2021

Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study

por Castellví, Ivan, Castillo, Diego, Corominas, Hèctor, Mariscal, Anaís, Orozco, Sandra, Benito, Natividad, Pomar, Virginia, Baucells, Andrés, Mur, Isabel, de la Rosa-Carrillo, David, Lobo, David, Millan, Ana Milena, Hernández de Sosa, Nerea, Filella, David, Matas, Laia, Martínez-Martínez, Laura, Juarez, Cándido, Casademont, Jordi, Domingo, Pere
Publicado 2022